On Friday, Cathie Wood– led Ark Invest made a number of substantial trades. The most popular amongst these included the trading of shares in Intellia Therapies Inc. NTLA, Meta Platforms Inc. META, Veracyte Inc. VCYT, Symbotic Inc. SYM, Baidu Inc. BIDU, and UiPath Inc. COURSE
The NTLA Trade: Ark Invest’s ARK Development ETF ARKK fund acquired 65,958 shares of Intellia Therapies. The shares were purchased a closing cost of $8.31, making the overall worth of the trade around $548,136.78. This relocation comes in the middle of a 1.59% boost in NTLA’s stock cost.
The META Trade: The ARK Autonomous Innovation & & Robotics ETF ARKK fund offered 1,255 shares of Meta Platforms at a closing cost of $547.27. The overall worth of this sale was around $686,324.85. This trade was performed as META’s stock cost saw a 2.65% boost.
The VCYT Trade: Ark Invest’s ARKK fund offered 66,135 shares of Veracyte. The shares were cost a closing cost of $32.23, making the overall worth of the trade around $2,131,151.05. This sale was made as VCYT’s stock cost experienced a small boost of 0.28%.
The SYM Trade: ARK Next Generation Web ETF ARKQ fund purchased 8,140 shares of Symbotic at a closing cost of $21.93. The overall worth of this purchase was around $178,410.20. This purchase was made in spite of SYM’s stock cost seeing a reduction of 0.59%.
The BIDU Trade: The ARKQ fund likewise purchased 925 shares of Baidu at a closing cost of $90.74. The overall worth of this purchase was around $83,934.50. This trade was performed as BIDU’s stock cost saw a 1.39% boost.
The Course Trade: Ark’s ARKW fund offered 984 shares of UiPath at a closing cost of $11.59. The overall worth of this sale was around $11,402.56. This sale was made as course’s stock cost experienced a 2.39% boost.
Read Next:
Disclaimer: This material was partly produced with the assistance of AI tools and was examined and released by Benzinga editors.
Image courtesy: Shutterstock
Market News and Data gave you by Benzinga APIs